Orbimed Advisors LLC Sutro Biopharma, Inc. Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $7.32 Million - $9.71 Million	-433,700 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $1.51 Million - $1.99 Million	83,700 Added 23.91%	433,700 $8.06 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $3.56 Million - $8.39 Million	350,000 New	350,000 $7.6 Million
Q2 2020 Aug 14, 2020	SELL	$7.24 - $11.05 $758,752 - $1.16 Million	-104,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.15 - $11.39 $854,120 - $1.19 Million	104,800 New	104,800 $1.15 Million

137

61M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $99.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.